• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An ion-exchange method for determining paraquat residues in food crops
  Analyst, 1965,90, 99-106

Compound Introduction: (2S)-1-cycloheptylpropan-2-amine (CAS No: 2227772-88-3)

(2S)-1-cycloheptylpropan-2-amine, identified by the Chemical Abstracts Service Number (CAS No) 2227772-88-3, is a specialized organic compound that has garnered attention in the field of pharmaceutical chemistry and biochemical research. This compound belongs to the class of amines, characterized by its unique structural configuration and potential biological activities. The presence of a cycloheptyl group appended to a propan-2-amine backbone imparts distinct chemical properties, making it a subject of interest for synthetic chemists and medicinal researchers.

The stereochemistry of (2S)-1-cycloheptylpropan-2-amine is particularly noteworthy, as the (S) configuration at the chiral center introduces specific interactions with biological targets. This chirality is often critical in drug design, where enantiomers can exhibit markedly different pharmacological profiles. The compound’s structure suggests potential applications in the development of chiral auxiliaries, ligands for asymmetric synthesis, or as a building block for more complex molecules.

In recent years, there has been growing interest in the exploration of structurally diverse amines for their therapeutic potential. (2S)-1-cycloheptylpropan-2-amine has been studied in the context of its possible role as an intermediate in the synthesis of bioactive molecules. Its cycloheptyl moiety can serve as a scaffold for further functionalization, enabling the creation of derivatives with tailored properties. Such derivatives may exhibit inhibitory effects on various enzymes or receptors, making them candidates for treating a range of diseases.

One of the most compelling aspects of (2S)-1-cycloheptylpropan-2-amine is its potential application in drug discovery programs aimed at identifying novel therapeutic agents. The compound’s unique structural features have been investigated in conjunction with computational chemistry methods to predict its binding affinity to biological targets. These studies have revealed that modifications to the cycloheptyl ring or the amine group could enhance its interaction with specific proteins or enzymes.

Moreover, the synthesis of (2S)-1-cycloheptylpropan-2-amine has been optimized using advanced synthetic techniques to ensure high enantiomeric purity. Chiral resolution and asymmetric synthesis methods have been employed to isolate the (S)-enantiomer, which is often preferred in pharmaceutical applications due to its improved pharmacokinetic properties. The synthetic pathways developed for this compound provide valuable insights into the construction of complex chiral molecules, which are essential for modern drug development.

Recent research has also highlighted the role of (2S)-1-cycloheptylpropan-2-amine in biochemical pathways and its potential as a probe molecule. Studies have demonstrated that this compound can interact with certain enzymes involved in metabolic processes, suggesting its utility in understanding disease mechanisms and developing targeted therapies. Additionally, its structural similarity to natural products has led to investigations into its role as a precursor for biologically active compounds derived from microbial sources.

The chemical properties of (2S)-1-cycloheptylpropan-2-amine, such as its solubility and stability, have been thoroughly characterized to facilitate its use in various applications. These properties are crucial for determining how the compound behaves in different environments, including biological systems and industrial processes. For instance, understanding its solubility profile helps in formulating it into effective drug delivery systems or optimizing its use in chemical reactions.

In conclusion, (2S)-1-cycloheptylpropan-2-amine (CAS No: 2227772-88-3) represents a significant advancement in pharmaceutical chemistry and biochemical research. Its unique structural features, stereochemical configuration, and potential biological activities make it a valuable asset in drug discovery and development efforts. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in addressing various medical challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)